Doris Howell, RN, PhD

Dr. Doris Howell was trained as a health services researcher and is now also focused on clinical intervention research. The goal of Dr. Howell's research program is to improve the patient's experience of cancer care, through health intervention research focused on better care delivery systems and clinical interventions for complex symptoms (fatigue, breathlessness, pain). Her main focus of intervention research is on understanding how psychological factors such as beliefs influence symptom response and adaptation to illness and how these might be modified through behavioral self-management interventions. Additionally, the efficacy and effectiveness of nurse-led behavioral self-management interventions in reducing symptom distress is a clinical research focus.

Dr. Howell also has an active health service research program focused on knowledge translation of best practices in care delivery, specifically the application of chronic disease self-management for survivorship. The testing of routine collection of Patient-Reported Outcomes (PRO) and their use in clinical practice to improve care quality and patient experience of cancer will enable this research.

Her research expertise includes qualitative and quantitative methods, with specific expertise in qualitative methods (hermeneutic phenomenology) and mixed-method study designs.

Dr. Howell leads standards and guideline development and is a member of the national distress management implementation team under the Canadian Partnership Against Cancer. Dr. Howell is the Co-Director of the Ontario Patient Reported Outcomes Symptom and Toxicities (On-PROST) and is cross-appointed as Professor (status) at the University of Toronto's Lawrence Bloomberg Faculty of Nursing.

BMC Cancer. 2019 Sep 05;19(1):884
Krzyzanowska MK, Julian JA, Powis M, Howell D, Earle CC, Enright KA, Mittmann N, Trudeau ME, Grunfeld E
Oncologist. 2019 Aug 13;:
Albaba H, Barnes TA, Veitch Z, Brown MC, Shakik S, Su S, Naik H, Wang T, Liang M, Perez-Cosio A, Eng L, Mittmann N, Xu W, Howell D, Liu G
Nurs Inq. 2019 Aug 09;:e12316
Mohammed S, Peter E, Gastaldo D, Howell D
Can Oncol Nurs J. 2019;29(2):97-102
Savage P, Murphy-Kane P, Lee CT, Chung CS, Howell D
Can Oncol Nurs J. 2019;29(2):103-109
Savage P, Murphy-Kane P, Lee CT, Chung CS, Howell D
Oncologist. 2019 Apr 05;:
O'Kane GM, Su J, Tse BC, Tam V, Tse T, Lu L, Borean M, Tam E, Labbé C, Naik H, Mittmann N, Doherty MK, Bradbury PA, Leighl NB, Shepherd FA, Richard NM, Edelstein K, Shultz D, Brown MC, Xu W, Howell D, Liu G
Cancer Med. 2019 Mar 21;:
Liu SY, Lu L, Pringle D, Mahler M, Niu C, Charow R, Tiessen K, Lam C, Halytskyy O, Naik H, Hon H, Irwin M, Pat V, Gonos C, Chan CWT, Villeneuve J, Shani RM, Chaudhry M, Brown MC, Selby P, Howell D, Xu W, Alibhai SMH, Jones JM, Liu G, Eng L
Pilot Feasibility Stud. 2019;5:39
Krzyzanowska MK, MacKay C, Han H, Eberg M, Gandhi S, Laferriere NB, Powis M, Howell D, Atzema CL, Chan KKW, Kukreti V, Mitchell S, Nayer M, Pasetka M, Knittel-Keren D, Redwood E
J Pain Symptom Manage. 2019 Mar 01;:
Barbera L, Sutradhar R, Howell D, Corn E, O'Brien MA, Seow H, Dudgeon D, Atzema C, Earle C, DeAngelis C, Sussman J



Adjunct Scientist, Cancer Care Ontario(CCO), Toronto
Co-Director of On-PROST (Ontario-Patient-Reported Outcomes on Symptoms and Toxicity), CCO
Professor (status), Lawrence Bloomberg Faculty of Nursing, University of Toronto
Cross-Appointment, Dalla Lana School of Public Health, University of Toronto